Matthew Winton - 06 Oct 2025 Form 4 Insider Report for CervoMed Inc. (CRVO)

Role: Chief Commercial and Business
Signature: /s/ Matthew Winton
Issuer symbol: CRVO
Transactions as of: 06 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 08 Oct 2025, 16:07:23 UTC
Previous filing: 03 Jul 2025
Next filing: 17 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Winton Matthew	Chief Commercial and Business	C/O CERVOMED INC., 20 PARK PLAZA, SUITE 424, BOSTON	/s/ Matthew Winton	07 Oct 2025	0001971400

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRVO	Stock Option (Right to Buy)	Award	$0	+75,000		$0.000000	75,000	06 Oct 2025	Common Stock	75,000	$8.62	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares granted as an inducement award material to Dr. Winton's entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). Award vests in equal monthly installments over thirty-six (36) months on the last day of each month commencing October 31, 2025.